Načítá se...
Evolution of resistance to anti-cancer therapy during general dosing schedules
Anti-cancer drugs targeted to specific oncogenic pathways have shown promising therapeutic results in the past few years; however, drug resistance remains an important obstacle for these therapies. Resistance to these drugs can emerge due to a variety of reasons including genetic or epigenetic chang...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2826560/ https://ncbi.nlm.nih.gov/pubmed/20004211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtbi.2009.11.022 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|